SB
Healthcare & Life Sciences
Sab Biotherapeutics
Sab Biotherapeutics is a Healthcare & Life Sciences startup, most recent round Series A, 2 tracked investors.
series-a
series-a
Stage
2
Investors
About Sab Biotherapeutics
Sab Biotherapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Develops a platform to generate fully-human antibody therapies with improved safety and pharmacological properties for treating autoimmune and infectious diseases.
Explore Sab Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.